Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soul CBD is a wellness-focused company specializing in the production and sale of high-quality, hemp-derived CBD products. Established by Angie Lee and Mike Lee, the brand was created to provide effective, THC-free solutions for common ailments such as anxiety, insomnia, and chronic pain. Their product line includes a variety of delivery formats, such as gummies, oil tinctures, and topical creams, all formulated with CBD isolate to ensure purity. Soul CBD emphasizes transparency and safety, subjecting every product batch to third-party lab testing and sourcing hemp from organic farms in the United States. The company primarily serves the consumer market through its e-commerce platform, positioning itself as a leader in the lifestyle-oriented cannabinoid space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soul CBD.